To evaluate the combinational effect of Ethyl Pyruvate, Berberine and Poloxamer 188 on 3 nitropropionic acid induced Huntingtons disease

Journal Title: Innovations in Pharmaceuticals and Pharmacotherapy (IPP) - Year 2018, Vol 6, Issue 2

Abstract

The present study is undertaken to study the combinational effect of ethyl pyruvate, berberine, and poloxamer 188 on 3-nitropropionic acid (3NP)-induced Huntington’s disease. 3NP is a well-versed experimental model to study Huntington’s disease (HD)-induced motor, memory, and mitochondrial dysfunctions. Ethyl pyruvate, berberine, and poloxamer 188 are reported to exhibit a neuroprotective effect in various animal models. Moreover, berberine is reported to have a protective effect on memory dysfunction. In addition, poloxamer-188 and ethyl pyruvate reduce muscular atrophy, neuronal loss, and neuroinflammation. These evidences suggest that either single or combination of these agents may protect against 3NP model. Administration of 3NP (10 mg/kg) for 14 days in male Wistar rats significantly induced HD-like symptoms in rats as indicated by reduced locomotor activity, body weight, grip strength, oxidative defense, cognition, and mitochondrial complex enzymes activities in striatum, cortex, and hippocampus. All the behavioral and biochemical studies on control and treatment groups were done after 14 days. Marked elevation in lactate dehydrogenase (LDH), succinate dehydrogenase (SDH), and lipid peroxidation was also observed. Furthermore, a decrease in the levels of reduced glutathione was noted. However, pretreatment of combination (ethyl pyruvate [40 mg/kg], berberine [50 mg/kg], and poloxamer 188 [40 mg/kg]) significantly attenuated behavioral alterations, oxidative stress, neuronal loss, and mitochondrial enzymes complex dysfunction in 3NP-treated group and potentiates their respective protective effects.In conclusion, a combination of ethyl pyruvate, poloxamer 188, and berberine could be used to manage behavioral and biochemical alterations in HD than either of single drug therapy

Authors and Affiliations

Pallavi Bhosle

Keywords

Related Articles

Permeability assessment of drug substances using in vitro and ex vivo screening techniques

Solubility and permeability are two important parameters used for the evaluation of drug substance to assess its bioavailability. Although dissolution can be studied using official dissolution apparatus, there are no off...

An in-silico approach on essential oil molecules as apoptosis inducer in cancer chemotherapy

Essential oils (EOs) are very engrossing natural plant products and apart from this they possess various biological properties. It has been reported that these essential oil molecules are able to inhibit tumor cell proli...

Antioxidant study on Cucurbita maxima fam Cucurbitaceae

In any biochemical process there is biotransformation of one set of chemical substances to another. Classically, chemical reactions encompass changes that only involve the positions of electrons in the forming and breaki...

Chemotherapy of tuberculosis: An updates

This review examines the chemotherapy of tuberculosis (TB) in humans which will help in the understanding and treatment of the disease. Tuberculosis is spread primarily by inhalation of aerosolized infectious droplet nuc...

Prediction of solubility of some chemicals in water, polyethylene glycol and their binary mixtures

With the aim of solubility A=πr2 estimation in water, polyethylene glycol 400 (PEG) and their binary mixtures, quantitative structure–property relationships (QSPR) were used to relate the solubility of a large number of...

Download PDF file
  • EP ID EP570163
  • DOI -
  • Views 85
  • Downloads 0

How To Cite

Pallavi Bhosle (2018). To evaluate the combinational effect of Ethyl Pyruvate, Berberine and Poloxamer 188 on 3 nitropropionic acid induced Huntingtons disease. Innovations in Pharmaceuticals and Pharmacotherapy (IPP), 6(2), 32-37. https://europub.co.uk/articles/-A-570163